Cancer Breakthrough


Italian researchers have discovered prostate cancer biomarkers able to identify patients with the best prognosis, with important implications for treatment.

The study was conducted over four years by the department of clinical and experimental medicine at Pisa University in conjunction with several hospital structures. The researchers applied a new form of results analysis leading to the identification of a particular genetic profile associated with greater overall survival, a statement said. Patients whose prognosis was found to be poor could consequently benefit from innovative drug therapies from the outset, while those with a good prognosis could opt for a less aggressive form of treatment.

There are no comments

Add yours

This site uses Akismet to reduce spam. Learn how your comment data is processed.